3i agrees Investment in OneMed from CapMan
3i, an international investor in private equity, infrastructure and debt management, and funds managed by 3i have signed an agreement to acquire OneMed, the leading northern European distributor of medical supplies to the healthcare services industry, from Nordic private equity firm CapMan.
OneMed distributes consumable medical products, devices and technology in the Nordics and Eastern Europe.
Since 2006, when OneMed was acquired by CapMan, the company has made a number of acquisitions to consolidate its market share and has worked to integrate these businesses and improve performance. Turnover has grown from circa €150m in 2006 to close to €400m in 2010.
3i’s investment represents a significant new step in OneMed’s development, providing a platform from which to accelerate the company’s consolidation of the industry and drive the business to become the market leader in northern Europe with further ambition to spread across Europe. In addition, 3i’s global network will enhance OneMed’s ability to access new suppliers, such as from Asia and provide supply chain improvements.
3i has extensive experience and a strong track record of investing in the healthcare sector as well as in supporting distribution and logistics businesses. Examples include the successful divestment of Ambea, a leading private provider of healthcare and care services across the Nordic region, Azelis, a leading pan-European distributor of specialty chemicals and Druck Chemie, the French and German market leader providing the printing industry with speciality chemicals, consumables and services.
Andreas Göthberg, OneMed CEO, commented: “OneMed has achieved tremendous growth during the four-year period demonstrating that a company operating in a fragmented and complex market can, with the assistance of an investment partner, make great progress. It is with confidence and enthusiasm that we enter this new chapter of our development.”
Mattias Eklund, 3i Nordic Partner and advisor to 3i Group, said: “We are excited to get the opportunity to support Andreas and his team in building the leading distributor of medical supplies and devices in northern and eastern Europe by providing customers with quality products at competitive prices and superior service levels. Our experience within healthcare and distribution and our deep Asian network fits OneMed well.”
Gustav Bard, 3i Nordic Chairman and advisor to 3i Group, commented: ”OneMed has in the last two years developed into one coherent business. It has gained a strong track record with positioning and scale for international expansion. We are excited to back OneMed on its next significant phase of organic and acquisition led development.”
For further information, please contact:
Mattias Eklund Tel: +46 8 506 101 52
Gustav Bard Tel: +46 8 506 101 51
Isabel Unsworth Tel: +44 20 7975 3190
Andreas Göthberg Tel: +46 7 302 043 00
CEO, OneMed Group Oy
Ari Tolppanen, Senior Partner Tel: +358 500 407343
3i is an international investor focused on Private Equity, Infrastructure and Debt Management, investing in Europe, Asia and North America. Our competitive advantage comes from our international network and the strength and breadth of our business relationships. These underpin the value that we deliver to our portfolio, shareholders and fund investors. http://www.3i.com/
3i's healthcare team has invested over €1.6bn in 36 healthcare companies since April 2001 across Europe, North America and Asia. We invest in Pharmaceuticals, Medical Technology and Healthcare Services companies led by management teams with a strong track record and the ambition to build lasting value. 3i's recent investments in the healthcare sector include: Qunitiles Transnational, Xellia (formerly Alpharma API) and LHi Technology.
OneMed is the leading medical supplies wholesaler in Northern Europe serving both public and private customers with reliable, high-quality products in medical supplies, other supplies & related products and medical equipment. The Company is present in Sweden, Finland, Poland, Denmark, Norway and the Baltic countries and had pro forma turnover of EUR 346 million and approximately 700 employees in 2009. OneMed's strategic intent is to be the One Partner in Medical Supplies.
CapMan is one of the leading alternative asset managers in the Nordic countries and Russia and manages private equity funds with approximately EUR 3.6 billion in total capital. CapMan has six investment areas (CapMan Buyout, CapMan Technology, CapMan Life Science, CapMan Russia, CapMan Public Market and CapMan Real Estate), and each of them has a dedicated team and funds. Altogether CapMan employs approximately 150 people in Helsinki, Stockholm, Copenhagen, Oslo, Moscow and Luxembourg. CapMan was established in 1989 and its B shares have been listed on the Helsinki Stock Exchange since 2001. http://www.capman.com/